Additionally, GLI1 immunostains can be utilized as well, however caution must be taken as GLI1 gene amplification is seen in a number of sarcomas and carcinomas leading to GLI1 protein overexpression and positive immunostaining which may lead to potential diagnostic pitfalls [8]. The gene discussed is GLI1; the disease is carcinoma.